|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
65.74(B) |
Last
Volume: |
1,691,719 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Borzi James W |
EVP & Chief Supply Chain Offcr |
|
2018-11-30 |
4 |
S |
$252.32 |
$1,485,692 |
D/D |
(5,887) |
2,775 |
|
- |
|
Borzi James W |
EVP & Chief Supply Chain Offcr |
|
2018-11-30 |
4 |
D |
$252.39 |
$1,600,910 |
D/D |
(6,343) |
5,551 |
|
- |
|
Borzi James W |
EVP & Chief Supply Chain Offcr |
|
2018-11-30 |
4 |
OE |
$134.73 |
$1,600,687 |
D/D |
10,405 |
7,538 |
|
- |
|
Reidy Christopher R |
CFO and EVP of Administration |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,948 |
26,084 |
|
- |
|
Reidy Christopher R |
CFO and EVP of Administration |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,261) |
23,662 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
38,364 |
212,901 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,243) |
202,740 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,988 |
16,455 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,711) |
13,168 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,434 |
17,612 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,418) |
15,623 |
|
- |
|
Borzi James W |
EVP & Chief Supply Chain Offcr |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,548 |
4,600 |
|
- |
|
Borzi James W |
EVP & Chief Supply Chain Offcr |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(201) |
3,432 |
|
- |
|
Bodner Charles R |
SVP Corp Fin Chief Acct Office |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,816 |
2,037 |
|
- |
|
Bodner Charles R |
SVP Corp Fin Chief Acct Office |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(826) |
1,647 |
|
- |
|
Lim James C |
Executive Vice President |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,875 |
17,193 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,544 |
6,247 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2018-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(703) |
5,879 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,168 |
32,505 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,211 |
13,473 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,862 |
4,395 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
995 |
9,890 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2018-11-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
104 |
212,797 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2018-11-19 |
4 |
S |
$243.86 |
$1,278,558 |
D/D |
(5,243) |
12,178 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2018-11-19 |
4 |
D |
$243.86 |
$1,578,994 |
D/D |
(6,475) |
17,421 |
|
- |
|
863 Records found
|
|
Page 18 of 35 |
|
|